Neimeth pays dividend as shareholders approve restructuring

Here's a possible news article based on the information you provided:

Neimeth Pharmaceuticals Pays Dividend as Shareholders Approve Restructuring

Lagos, Nigeria - Neimeth Pharmaceuticals, a leading pharmaceutical company in Nigeria, has announced that it has paid a dividend to its shareholders following the approval of its restructuring plan.

The company's shareholders had earlier approved the restructuring plan, which aimed to reorganize the company's operations and improve its financial performance. The plan was designed to enhance the company's competitiveness in the Nigerian pharmaceutical market and position it for future growth.

As part of the restructuring plan, Neimeth Pharmaceuticals had announced plans to divest from some of its non-core businesses and focus on its core pharmaceutical operations. The company had also announced plans to reduce its debt and improve its cash flow.

The payment of the dividend to shareholders is a testament to the company's commitment to rewarding its investors for their support and trust in the company. The dividend payment is also a reflection of the company's improved financial performance, which has been driven by its restructuring efforts.

"We are pleased to announce that we have paid a dividend to our shareholders as a result of our restructuring efforts," said the Managing Director of Neimeth Pharmaceuticals. "This is a significant milestone for our company and a testament to our commitment to creating value for our shareholders."

The company's restructuring plan has been widely praised by analysts and investors, who see it as a positive step towards improving the company's financial performance and competitiveness in the market.

Neimeth Pharmaceuticals is a leading pharmaceutical company in Nigeria, with a portfolio of over 100 products. The company has a strong presence in the Nigerian market and is known for its high-quality products and excellent customer service.

Contact: [Name] [Email] [Phone]